Indeed, the SARS-CoV-2 Metagene signature, generated by utilizing the above-mentioned 23 genes, was able to discriminate breast cancer patients with different OS only in the premenopausal luminal A subgroup, suggesting that the coordinated biological functions of these genes may impact breast cancer biology and clinical outcomes only when estrogen receptor signaling is active. This evidence concerns the gene ESR1 and breast carcinoma.